Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a publication citation for MAESTRO-NASH (Schattenberg et al., J Hepatol) and removed MedlinePlus Genetics as a related topic.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the Study Details page.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAdded the related topic 'Non-alcoholic fatty liver disease' to the study page and updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved related topics: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this is a minor update that does not affect the page content or its primary functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.